###begin article-title 0
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
The yeast high mobility group protein HMO2, a subunit of the chromatin-remodeling complex INO80, binds DNA ends
###end article-title 0
###begin p 1
###xml 61 85 61 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 61 85 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
DNA damage is a common hazard that all cells have to combat. Saccharomyces cerevisiae HMO2 is a high mobility group protein (HMGB) that is a component of the chromatin-remodeling complex INO80, which is involved in double strand break (DSB) repair. We show here using DNA end-joining and exonuclease protection assays that HMO2 binds preferentially to DNA ends. While HMO2 binds DNA with both blunt and cohesive ends, the sequence of a single stranded overhang significantly affects binding, supporting the conclusion that HMO2 recognizes features at DNA ends. Analysis of the effect of duplex length on the ability of HMO2 to protect DNA from exonucleolytic cleavage suggests that more than one HMO2 must assemble at each DNA end. HMO2 binds supercoiled DNA with higher affinity than linear DNA and has a preference for DNA with lesions such as pairs of tandem mismatches; however, comparison of DNA constructs of increasing length suggests that HMO2 may not bind stably as a monomer to distorted DNA. The remarkable ability of HMO2 to protect DNA from exonucleolytic cleavage, combined with reports that HMO2 arrives early at DNA DSBs, suggests that HMO2 may play a role in DSB repair beyond INO80 recruitment.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 508 511 508 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5 B6 B7">3&#8211;7</xref>
All organisms depend on efficient repair of DNA double strand breaks (DSBs) to maintain genomic stability (1,2). The most accurate repair pathway is homologous recombination (HR), which is mainly active during S and G2 as it depends on the presence of sister chromatids, while the more error prone non-homologous end-joining (NHEJ) is active throughout the cell cycle (2). Both repair pathways must negotiate DNA that is packaged into chromatin, and chromatin remodeling is therefore critical to DNA repair (3-7).
###end p 3
###begin p 4
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8 B9 B10 B11">8&#8211;11</xref>
###xml 535 536 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 109 114 <span type="species:ncbi:4932">yeast</span>
The ATP-dependent chromatin remodeling complex INO80 has been recently shown to participate in DSB repair in yeast (3,8-11). The INO80 complex is recruited to the DSB by interaction with the damage-induced phosphorylated histone H2A (gamma-H2AX), a phenomenon that requires the high mobility group protein (HMGB) HMO2 (also known as NHP10). HMO2 has been reported to be responsible for interaction with gamma-H2AX and its inactivation results in reduced INO80 recruitment to the DSB, but not to impaired chromatin remodeling activity (3). Since H2A phosphorylation is thought to be an early response to DSB formation, INO80-and hence HMO2-may contribute to DSB repair by both pathways.
###end p 4
###begin p 5
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 272 274 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 275 277 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 591 593 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 594 599 582 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14 B15 B16 B17 B18 B19">14&#8211;19</xref>
###xml 681 686 665 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14 B15 B16 B17">14&#8211;17</xref>
###xml 687 692 671 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19 B20 B21">19&#8211;21</xref>
###xml 825 827 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 828 830 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 831 833 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 923 925 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 926 928 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1235 1243 1219 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1275 1280 1259 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24 B25 B26 B27">24&#8211;27</xref>
###xml 1281 1282 1265 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 559 564 <span type="species:ncbi:4932">yeast</span>
High mobility group (HMG) proteins are non-histone chromosomal proteins that are classified into three groups, HMGA, HMGB and HMGN depending on their DNA-binding characteristics (12,13). HMGB proteins contain one or more HMG boxes, an approximately80 amino-acid sequence (13,14), and are further classified into two groups depending on sequence specificity; the sequence-specific family consists of transcription factors such as lymphoid enhancer factor (LEF) and sex-determining factor (SRY), while the non-sequence specific family includes HMGB1, HMGB2 and yeast homologs NHP6A and NHP6B (12,14-19). The HMG box is composed of three alpha-helices which adopt an 'L' shaped fold (14-17,19-21). Binding to the DNA occurs through the minor groove by partial intercalation of hydrophobic amino acids, resulting in DNA bending (12,18,21), and HMGB proteins preferentially bind to distorted DNA such as cisplatin-modified DNA (22,23). HMGB proteins participate in stabilizing chromatin structure and play a role in DNA-dependent processes such as recombination and transcription by facilitating nucleoprotein complex assembly. HMGB proteins have also been suggested to contribute to DNA repair, as evidenced for example by DNA end-joining in vitro in the presence of DNA ligase (24-27).
###end p 5
###begin p 6
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 151 156 151 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28 B29 B30">28&#8211;30</xref>
###xml 461 466 461 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31 B32 B33 B34 B35 B36">31&#8211;36</xref>
###xml 625 626 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 843 845 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 846 848 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae contains 10 HMGB proteins. The single HMG box proteins NHP6A/B participate in transcription by RNA polymerases II and III (18,28-30). HMO1 and HMO2 are more similar to mammalian HMGB proteins by having two HMG-like domains, Box A and Box B. HMO1 has been shown to play a role in plasmid maintenance and normal growth and it also functions in the ribosomal RNA transcription system as well as in regulating ribosomal protein expression (31-36). In the approximately25-kDa HMO2, the two domains Box A and Box B are followed by an acidic C-terminal tail in contrast to HMO1, which has a lysine-rich tail. For both HMO1 and HMO2, Box B corresponds to the mammalian Box B while the N-terminal Box A bears little resemblance to mammalian Box A. The HMO1 Box A domain has been shown to contribute to DNA binding and bending (37,38).
###end p 6
###begin p 7
We show here that HMO2 binds to DNA ends, both blunt ends and overhangs, and that it protects DNA from exonuclease digestion. Since protection of DNA ends from exonucleolytic cleavage is essential to minimize loss of genetic information before repair can be initiated, and since HMO2 is thought to arrive early at DSBs in its complex with INO80 components, our data suggests that HMO2 may play a role in DSB repair beyond INO80 recruitment.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Cloning, overexpression and purification of protein
###end title 9
###begin p 10
###xml 92 98 92 98 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</underline>
###xml 133 139 133 139 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</underline>
###xml 271 272 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 311 327 311 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 411 412 408 409 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 446 449 443 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 569 570 566 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 569 570 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>x</sub></italic>
###xml 571 572 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</sub>
###xml 571 572 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>y</sub></italic>
###xml 574 575 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 975 976 971 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1180 1181 1176 1177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 1180 1181 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>x</sub></italic>
###xml 1182 1183 1178 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</sub>
###xml 1182 1183 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>y</sub></italic>
###xml 1185 1186 1181 1182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1345 1346 1341 1342 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 1345 1346 1341 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>x</sub></italic>
###xml 1347 1348 1343 1344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</sub>
###xml 1347 1348 1343 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>y</sub></italic>
###xml 1350 1351 1346 1347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1744 1746 1740 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 42 47 <span type="species:ncbi:4932">yeast</span>
###xml 311 327 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1512 1518 <span type="species:ncbi:9913">bovine</span>
The gene-encoding HMO2 was amplified from yeast genomic DNA using primers NHP10F 5'-CACATAAGCATATGTCAGTTGAA-3' and NHP10R 5'-CGTCTTACCATATGTTCAAAGAA-3' (NdeI sites underlined) and cloned into the NdeI site of pET14b, resulting in expression of HMO2 with an N-terminal His6-tag. pET14b-HMO2 was transformed into Escherichia coli Rosetta Blue and expression of HMO2 was induced by addition of 1 mM isopropyl-beta-d-thiogalactopyranoside (IPTG) at A600 of 0.2 and induction was carried out for 4 h. Cells were pelleted and then resuspended in lysis buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl, 10 mM imidazole, 20% glycerol, 1 mM 2-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride (PMSF)). Cells were disrupted by sonication. The nucleic acids were digested by adding 2 mul of 2000 U/ml of DNaseI (New England Biolabs) and incubated on ice for 1 h. To the lysate, 0.01% of Triton X-100 was added and the solution was incubated on ice for 1 h and then centrifuged at 6000 x g for 20 min. The lysate was incubated with Ni-NTA agarose beads for 1 h on ice. The nickel beads were equilibrated using lysis buffer prior to use. The beads were washed using wash buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl, 20 mM imidazole, 20% glycerol, 1 mM 2-mercaptoethanol and 1 mM PMSF). Proteins were eluted by gravity flow using elution buffer pH 7.5 (50 mM NaxHyPO4, 300 mM NaCl, 250 mM imidazole, 20% glycerol, 1 mM 2-mercaptoethanol and 1 mM PMSF). Pure HMO2 was quantitated using Coomassie blue stained SDS-PAGE gels using bovine serum albumin as standard as well as by Micro BCA Protein Assay Kit (Pierce). At least three independent preparations of HMO2 were used, indicating reproducibility of the preparations. HMO1 was obtained as described earlier (37).
###end p 10
###begin title 11
Agarose gel retardation
###end title 11
###begin p 12
One hundred nanograms of supercoiled or linear pGEM5 was incubated at 4degreesC with different concentrations of HMO2 in 10 mul reaction buffer (20 mM Tris pH 8.0, 0.1 M EDTA, 15 mM NaCl, 0.1 mM DTT and 0.01% BRIJ 58). Complexes were resolved using 1% TBE agarose gels using 0.5x TBE buffer (50 mM Tris borate, 1 mM EDTA) and visualized by ethidium bromide staining.
###end p 12
###begin title 13
DNA supercoiling
###end title 13
###begin p 14
###xml 773 790 760 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus subtilis</italic>
###xml 773 790 <span type="species:ncbi:1423">Bacillus subtilis</span>
Supercoiled pUC18 was nicked using Nt.BstNBI (New England Biolabs). One hundred nanograms of nicked DNA was incubated with varying concentration of HMO2, at room temperature for 1 h. Reactions were initiated using 1 mul of 80 U/mul of T4 DNA ligase (New England Biolabs) in presence of ligase buffer and incubated at room temperature for 1 h. Reactions were terminated using 1 mul stop buffer (5 mM EDTA, 1.1% glycerol and 0.2 mg/ml proteinase K final concentration) and incubated at 37degreesC for 1 h. Samples were loaded on 1% TBE agarose gels and electrophoresed for 14 h followed by staining with ethidium bromide. For determination of the direction of DNA supercoils produced by HMO2, electrophoresis was performed in the presence of 0.3 microg/ml chloroquine, using Bacillus subtilis HU as a control.
###end p 14
###begin title 15
Electrophoretic mobility shift assay
###end title 15
###begin p 16
###xml 452 454 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 559 561 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
All oligonucleotides used for preparation of DNA constructs were purchased and purified by denaturing gel electrophoresis. Sequences are available in . Electrophoretic Mobility Shift Assays (EMSAs) were performed using DNA duplex and DNA with loops, nicks, gaps and overhangs. A common 37-nt oligonucleotide was used to generate the different constructs. The top strand was 5'-end labeled using T4 polynucleotide kinase (New England Biolabs) and [gamma32P] ATP. The sequences of duplex as well as DNA with nick, gap, loops and overhangs were as described in (39) or presented in . Top and bottom strands were annealed by heating at 90degreesC and slowly cooling to room temperature. Similarly, a 50 bp DNA duplex and duplex with either a single or tandem loops was generated by extending the 37 bp construct at both ends. Reactions contained 5 fmol of DNA substrate and varying concentration of HMO2 in 10 mul reaction buffer (20 mM Tris pH 8.0, 0.1 mM EDTA, 5 mM NaCl, 0.1 mM DTT, 0.01% BRIJ 58 and 0.1% Triton X-100) and incubated at room temperature for 1 h. Experiments designed to compare different DNA constructs were performed side-by-side with the same protein preparation. Samples were loaded on a prerun 8% polyacrylamide gel (39 : 1 acrylamide:bisacrylamide) and electrophoresed using 0.5x TBE at 175 V for 2 h. Complexes were visualized using Amersham Biosciences Storm Phosphorimager. Reactions were performed at least in duplicate.
###end p 16
###begin title 17
EMSA with four-way junctions
###end title 17
###begin p 18
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
The sequence of the four-way junctions (4WJ) was described in (39) and shown in . 4WJ were obtained by 5'-end labeling one strand and annealing the other three strands, followed by purification using native polyacrylamide gels. Complete annealing of all strands was determined by comparing the electrophoretic mobility to that of annealed constructs lacking one of the unlabeled strands. EMSA was performed as described above using 5 fmol of DNA and varying concentration of HMO2 in reaction buffer. Final volume of the reaction was 10 mul.
###end p 18
###begin title 19
Competition assay
###end title 19
###begin p 20
Five fmol 50-bp duplex DNA with loops and 4-muM of HMO2 was incubated at room temperature for 1 h in reaction buffer. Supercoiled or linear pGEM5 (0.5-50 fmol) was added and incubated at room temperature for 1 h; pGEM5 was linearized with NdeI or AatII. Samples were electrophoresed on prerun 8% polyacrylamide gels. Complexes were viewed using Storm Phosphorimager.
###end p 20
###begin title 21
End-joining assay
###end title 21
###begin p 22
Supercoiled pGEM5 was digested with NdeI or NaeI to obtain DNA with a 2-nt 5' overhang or blunt ends, respectively. One hundred nanograms of linearized pGEM5 was incubated with varying concentrations of HMO2 or HMO1 at room temperature for 1 h. To this reaction, 1 mul of 400 U/mul of T4 DNA ligase was added and incubated at room temperature for 1 h. Samples were treated with exonuclease III (100 U/mul) at room temperature for 1 h. Reactions were terminated by adding 2 mul stop buffer (5 mM EDTA, 1.1% glycerol and 0.2 mg/ml proteinase K). Alternatively, supercoiled pET5a was digested with BspHI, which creates a 4-nt 5' overhang. One hundred nanograms of the linearized pET5a was incubated with 2 microM HMO2. To this reaction 1 microl of 400 U/microl of T4 DNA ligase was added and incubated at room temperature for 1 h. Reactions were terminated by adding 2 microl of stop buffer. Samples were electrophoresed on 1% TBE agarose gels and visualized by ethidium bromide staining.
###end p 22
###begin p 23
###xml 32 38 32 38 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 460 471 460 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. subtilis</italic>
###xml 460 471 <span type="species:ncbi:1423">B. subtilis</span>
Using forward primer 5'-TGGGGTGCGAATTCTAATGAGT-3' and reverse primer 5'-GGCTTTACACTTTATGCTTCCG-3', an extra EcoRI site was introduced into plasmid pUC18 by PCR amplification. The pUC18 variant was then digested with EcoRI to obtain 105 bp DNA duplex with 5'-AATT extensions. The 105 bp DNA was 5'-end labeled using T4 polynucleotide kinase (New England Biolabs). One hundred femtomoles of 105 bp DNA was incubated with varying concentrations of HMO2 or 100 nM B. subtilis HU at room temperature for 1 h. To this reaction, 1 microl of 8 U/microl T4 DNA ligase was added and incubated at room temperature for 1 h. Samples were treated with exonuclease III (100 U/microl) at room temperature for 1 h. Reactions were terminated by adding 2 microl stop buffer and 1 microl of 10% SDS and then phenol chloroform extracted and ethanol precipitated. Samples were loaded on a prerun 5% polyacrylamide gel (39:1 acrylamide:bisacrylamide) and electrophoresed using 0.5x TBE at 175 V for 2 h. Complexes were visualized using Amersham Biosciences Storm Phosphorimager.
###end p 23
###begin title 24
Exonuclease III protection assay
###end title 24
###begin p 25
Supercoiled pGEM5 was linearized with NdeI or NaeI to yield DNA with 2-nt 5' overhangs or blunt ends, respectively. pET5a was digested with BspHI to produce 4-nt 5' overhang, pUC18 was digested with EcoRI, which also produces a 4-nt 5' overhang, and a pcDNA3-derivative was digested with ApoI, which likewise creates a 4-nt 5' overhang. pET5a was digested with ScaI and then PvuI (which cuts supercoiled DNA only poorly), to yield a blunt end and 2-nt 3' overhang, respectively. pRAD1 was digested with DraI to produce blunt ends. Fifty to one hundred nanograms of linearized pGEM5, pET5a, pUC18, pcDNA3-derivative and pRAD1 was incubated at room temperature for 1 h with 2 muM HMO2 or HMO1 previously dialyzed using dialysis buffer (50 mM Tris pH 8.0, 50 mM NaCl and 20% glycerol). To each reaction, 1 mul of 100 U/mul exonuclease III was added and incubated at room temperature for 1 h. Reactions were terminated by addition of 2 mul 10% SDS or by phenol-extraction and ethanol precipitation (the latter in cases where shorter DNA fragments are produced that may co-migrate with SDS on the gels). Samples were electrophoresed on 1% TBE agarose gels. Gels were stained with ethidium bromide. All reactions were performed at least in duplicate, and pGEM5 digested with NdeI to produce 5'-TA overhangs was included for comparison to other DNA constructs.
###end p 25
###begin title 26
DNase I protection assay
###end title 26
###begin p 27
One hundred nanograms of supercoiled or linearized pGEM5 with blunt ends or overhangs were incubated at room temperature for 1 h with 1 muM HMO2 in 10 mul reaction buffer. One microliter of 0.1 U/mul DNaseI (New England Biolabs) was added in presence of DNase I buffer and incubated for 1, 2.5 and 5 min. Reactions were terminated by adding 2 mul of stop buffer and incubating at 37degreesC for 30 min, followed by addition of 1 mul of 10% SDS. Samples were electrophoresed on 1% TBE agarose gels. Gels were stained with ethidium bromide.
###end p 27
###begin title 28
RESULTS
###end title 28
###begin title 29
HMO2 binds preferentially to distorted DNA compared to linear duplex
###end title 29
###begin p 30
###xml 276 284 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli.</italic>
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 672 680 672 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 751 759 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 953 962 953 962 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1001 1002 1001 1002 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1004 1005 1004 1005 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1251 1252 1249 1250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 962 1466 962 1464 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="31">Interaction of HMO2 with plasmid DNA. (<bold>A</bold>, <bold>B</bold>) Agarose gel retardation of 100 ng plasmid DNA titrated with HMO2. (A) Reactions with supercoiled pGEM5. Lane 1, DNA only, lanes 2&#8211;7 with 1.0&#8211;6.0 &#956;M HMO2. (B) Reactions with linearized pGEM5. Lane 1, DNA only, lanes 2&#8211;6 with 1.0&#8211;5.0 &#956;M HMO2. (<bold>C</bold>) HMO2 supercoils relaxed DNA. Lane 1, 100 ng supercoiled pUC18 DNA. Lane 2, nicked pUC18. Lane 3, nicked pUC18 and T4 DNA ligase. Lanes 4&#8211;8, nicked DNA and T4 DNA ligase with 100, 500, 1000, 2000 and 3000 nM HMO2.</p>
###xml 962 1466 962 1464 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="31">Interaction of HMO2 with plasmid DNA. (<bold>A</bold>, <bold>B</bold>) Agarose gel retardation of 100 ng plasmid DNA titrated with HMO2. (A) Reactions with supercoiled pGEM5. Lane 1, DNA only, lanes 2&#8211;7 with 1.0&#8211;6.0 &#956;M HMO2. (B) Reactions with linearized pGEM5. Lane 1, DNA only, lanes 2&#8211;6 with 1.0&#8211;5.0 &#956;M HMO2. (<bold>C</bold>) HMO2 supercoils relaxed DNA. Lane 1, 100 ng supercoiled pUC18 DNA. Lane 2, nicked pUC18. Lane 3, nicked pUC18 and T4 DNA ligase. Lanes 4&#8211;8, nicked DNA and T4 DNA ligase with 100, 500, 1000, 2000 and 3000 nM HMO2.</p></caption>
###xml 1466 1466 1464 1464 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f1"/>
###xml 953 1466 953 1464 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="31">Interaction of HMO2 with plasmid DNA. (<bold>A</bold>, <bold>B</bold>) Agarose gel retardation of 100 ng plasmid DNA titrated with HMO2. (A) Reactions with supercoiled pGEM5. Lane 1, DNA only, lanes 2&#8211;7 with 1.0&#8211;6.0 &#956;M HMO2. (B) Reactions with linearized pGEM5. Lane 1, DNA only, lanes 2&#8211;6 with 1.0&#8211;5.0 &#956;M HMO2. (<bold>C</bold>) HMO2 supercoils relaxed DNA. Lane 1, 100 ng supercoiled pUC18 DNA. Lane 2, nicked pUC18. Lane 3, nicked pUC18 and T4 DNA ligase. Lanes 4&#8211;8, nicked DNA and T4 DNA ligase with 100, 500, 1000, 2000 and 3000 nM HMO2.</p></caption><graphic xlink:href="gkp695f1"/></fig>
###xml 237 242 <span type="species:ncbi:4932">yeast</span>
###xml 276 283 <span type="species:ncbi:562">E. coli</span>
While HMO2 has been proposed to interact with a damage-induced histone H2A variant, conservation of its Box B HMG-domain predicts direct DNA interaction. To investigate a potential role in DNA interaction, HMO2 was therefore cloned from yeast genomic DNA and overexpressed in E. coli. HMO2 was judged to be >95% pure using Coomassie blue stained SDS-PAGE gels (). Consistent with the presence of the classical Box B HMG domain, HMO2 binds both supercoiled and linear DNA (Figure 1) suggesting non-sequence-specific binding as seen for other chromatin-associated HMGB proteins. While the mobility of HMO2-associated linear DNA is gradually reduced as a function of [HMO2] (Figure 1B), the mobility of supercoiled DNA is enhanced at the highest [HMO2] (Figure 1A), suggesting DNA compaction. Note also that ethidium bromide staining of HMO2-bound DNA is enhanced compared to free DNA, perhaps reflecting a DNA unwinding by HMO2 that promotes dye-binding. Figure 1.Interaction of HMO2 with plasmid DNA. (A, B) Agarose gel retardation of 100 ng plasmid DNA titrated with HMO2. (A) Reactions with supercoiled pGEM5. Lane 1, DNA only, lanes 2-7 with 1.0-6.0 muM HMO2. (B) Reactions with linearized pGEM5. Lane 1, DNA only, lanes 2-6 with 1.0-5.0 muM HMO2. (C) HMO2 supercoils relaxed DNA. Lane 1, 100 ng supercoiled pUC18 DNA. Lane 2, nicked pUC18. Lane 3, nicked pUC18 and T4 DNA ligase. Lanes 4-8, nicked DNA and T4 DNA ligase with 100, 500, 1000, 2000 and 3000 nM HMO2.
###end p 30
###begin p 31
###xml 39 40 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 289 290 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Interaction of HMO2 with plasmid DNA. (A, B) Agarose gel retardation of 100 ng plasmid DNA titrated with HMO2. (A) Reactions with supercoiled pGEM5. Lane 1, DNA only, lanes 2-7 with 1.0-6.0 muM HMO2. (B) Reactions with linearized pGEM5. Lane 1, DNA only, lanes 2-6 with 1.0-5.0 muM HMO2. (C) HMO2 supercoils relaxed DNA. Lane 1, 100 ng supercoiled pUC18 DNA. Lane 2, nicked pUC18. Lane 3, nicked pUC18 and T4 DNA ligase. Lanes 4-8, nicked DNA and T4 DNA ligase with 100, 500, 1000, 2000 and 3000 nM HMO2.
###end p 31
###begin p 32
###xml 61 69 61 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 614 622 614 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
Like other HMGB proteins, HMO2 can constrain DNA supercoils (Figure 1C). When nicked plasmid was incubated with HMO2 in presence of T4 DNA ligase, HMO2 was found to introduce supercoils to the relaxed DNA. Electrophoresis in the presence of chloroquine indicates the expected introduction of negative supercoils by HMO2 (i.e., a slower migration of topoisomers in the presence of chloroquine; data not shown). This is in consensus with other HMGB proteins which can supercoil relaxed DNA (31). The ability of HMO2 to introduce supercoils is consistent with the DNA compaction seen on interaction with plasmid DNA (Figure 1A).
###end p 32
###begin p 33
###xml 106 114 106 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 562 570 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 761 769 761 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 947 955 947 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1009 1017 1009 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1284 1286 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1826 1828 1826 1828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1829 1831 1829 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1832 1834 1832 1834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 2217 2219 2217 2219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 2367 2368 2367 2368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 2455 2456 2455 2456 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 2515 2524 2515 2524 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 2591 2592 2591 2592 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2659 2660 2659 2660 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2662 2663 2662 2663 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2861 2862 2861 2862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3092 3093 3092 3093 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2524 3255 2524 3255 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">HMO2 binds preferentially to DNA with pairs of tandem mismatches. (<bold>A</bold>) EMSA of 50 bp DNA duplex and increasing concentrations of HMO2. (<bold>B</bold>, <bold>C</bold>) EMSA of 50 bp DNA duplex with a single loop (tandem mismatches) and increasing concentrations of HMO2; (B) loop composed of opposing AA nucleotides, (C) loop composed of opposing CT nucleotides. (<bold>D</bold>) EMSA of 50 bp DNA duplex with both AA and CT loops separated by 9 bp of duplex and increasing concentrations of HMO2. Lanes 1, reactions with DNA only, lanes 2&#8211;8, reactions with 50, 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. (<bold>E</bold>) EMSA of four way junction DNA. Lane 1, 5 fmol of four way junction only. Lanes 2&#8211;10, reactions with 50, 100, 500, 1000, 2000, 3000, 4000, 5000 and 6000 nM HMO2.</p>
###xml 2524 3255 2524 3255 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">HMO2 binds preferentially to DNA with pairs of tandem mismatches. (<bold>A</bold>) EMSA of 50 bp DNA duplex and increasing concentrations of HMO2. (<bold>B</bold>, <bold>C</bold>) EMSA of 50 bp DNA duplex with a single loop (tandem mismatches) and increasing concentrations of HMO2; (B) loop composed of opposing AA nucleotides, (C) loop composed of opposing CT nucleotides. (<bold>D</bold>) EMSA of 50 bp DNA duplex with both AA and CT loops separated by 9 bp of duplex and increasing concentrations of HMO2. Lanes 1, reactions with DNA only, lanes 2&#8211;8, reactions with 50, 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. (<bold>E</bold>) EMSA of four way junction DNA. Lane 1, 5 fmol of four way junction only. Lanes 2&#8211;10, reactions with 50, 100, 500, 1000, 2000, 3000, 4000, 5000 and 6000 nM HMO2.</p></caption>
###xml 3255 3255 3255 3255 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f2"/>
###xml 2515 3255 2515 3255 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="34">HMO2 binds preferentially to DNA with pairs of tandem mismatches. (<bold>A</bold>) EMSA of 50 bp DNA duplex and increasing concentrations of HMO2. (<bold>B</bold>, <bold>C</bold>) EMSA of 50 bp DNA duplex with a single loop (tandem mismatches) and increasing concentrations of HMO2; (B) loop composed of opposing AA nucleotides, (C) loop composed of opposing CT nucleotides. (<bold>D</bold>) EMSA of 50 bp DNA duplex with both AA and CT loops separated by 9 bp of duplex and increasing concentrations of HMO2. Lanes 1, reactions with DNA only, lanes 2&#8211;8, reactions with 50, 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. (<bold>E</bold>) EMSA of four way junction DNA. Lane 1, 5 fmol of four way junction only. Lanes 2&#8211;10, reactions with 50, 100, 500, 1000, 2000, 3000, 4000, 5000 and 6000 nM HMO2.</p></caption><graphic xlink:href="gkp695f2"/></fig>
###xml 1801 1806 <span type="species:ncbi:4932">yeast</span>
DNA binding was analyzed further using EMSA. HMO2 does not form detectable complex with 50-bp DNA duplex (Figure 2A) most likely reflecting that complexes are unstable and dissociate during electrophoresis since association with longer DNA clearly leads to stable complex formation (Figure 1). Mammalian HMGB was previously shown to bind preferentially to 37 bp DNA containing a pair of loops (tandem mismatches) separated by 9 bp of duplex (40). Using the same set of mismatches in the context of 50 bp duplex (), HMO2 was seen to form a single stable complex (Figure 2D) indicating preferred binding to the looped DNA construct. Notably, association with the tandem-loop construct leads to enhanced complex formation compared to 50 bp DNA with a single loop (Figure 2B and C), and binding to the 50 bp duplex containing the CT loop (in which the sequence of the bottom strand contains a 3'-CT-5'-sequence, resulting in identical opposing bases; Figure 2C) is more stable than the 50 bp duplex with AA loop (Figure 2B), perhaps indicating that the sequence of the nucleotides at the loop results in differential DNA distortion, which in turn affects HMO2 binding [an interpretation based on reported differential dynamic properties of DNA with different base mismatches; e.g., ref. (41)], or inherent sequence preferences of HMO2. Complex formation was generally more defined in presence of detergent as HMO2 self-associates in its absence (not shown); we therefore also had to consider the possibility that equilibrium binding conditions include a contribution from monomeric HMO2 dissociating from a larger aggregate when diluted from a concentrated stock solution, even in the presence of detergent, and we elected not to calculate a binding constant. Such self-association was also noted for the yeast HMGB homolog HMO1 (31,37,38). With the 37 bp DNA duplex with tandem loops, HMO2 forms an unstable but detectable complex, while no preferred binding was seen to 37 bp DNA with a single nick, gap or overhang (consistent with the observation that HMO2 binds preferentially to 50 bp DNA with two separate lesions; data not shown). In contrast to HMO1, HMO2 also does not form a detectable complex with 26 bp DNA (37). Evidently, HMO2 binds preferentially to DNA with a pair of lesions, but only in duplex DNA of sufficient length. On removal of the N-terminal His6-tag, no difference was observed in DNA binding indicating that the presence of the His6-tag does not interfere with DNA binding (data not shown). Figure 2.HMO2 binds preferentially to DNA with pairs of tandem mismatches. (A) EMSA of 50 bp DNA duplex and increasing concentrations of HMO2. (B, C) EMSA of 50 bp DNA duplex with a single loop (tandem mismatches) and increasing concentrations of HMO2; (B) loop composed of opposing AA nucleotides, (C) loop composed of opposing CT nucleotides. (D) EMSA of 50 bp DNA duplex with both AA and CT loops separated by 9 bp of duplex and increasing concentrations of HMO2. Lanes 1, reactions with DNA only, lanes 2-8, reactions with 50, 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. (E) EMSA of four way junction DNA. Lane 1, 5 fmol of four way junction only. Lanes 2-10, reactions with 50, 100, 500, 1000, 2000, 3000, 4000, 5000 and 6000 nM HMO2.
###end p 33
###begin p 34
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 135 136 135 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 138 139 138 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 568 569 568 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
HMO2 binds preferentially to DNA with pairs of tandem mismatches. (A) EMSA of 50 bp DNA duplex and increasing concentrations of HMO2. (B, C) EMSA of 50 bp DNA duplex with a single loop (tandem mismatches) and increasing concentrations of HMO2; (B) loop composed of opposing AA nucleotides, (C) loop composed of opposing CT nucleotides. (D) EMSA of 50 bp DNA duplex with both AA and CT loops separated by 9 bp of duplex and increasing concentrations of HMO2. Lanes 1, reactions with DNA only, lanes 2-8, reactions with 50, 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. (E) EMSA of four way junction DNA. Lane 1, 5 fmol of four way junction only. Lanes 2-10, reactions with 50, 100, 500, 1000, 2000, 3000, 4000, 5000 and 6000 nM HMO2.
###end p 34
###begin p 35
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 211 216 211 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42 B43 B44">42&#8211;44</xref>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
HMGB proteins generally also have higher affinity for four-way junction DNA compared to perfect duplex DNA, provided the absence of Mg2+, which would induce a disfavored stacked X conformation of the junctions (42-44). HMO2, however, has only a modest preference for the four-way DNA junctions in absence of Mg2+ (Figure 2E) compared to perfect duplex DNA and forms complex comparable to that seen with DNA containing a single lesion.
###end p 35
###begin p 36
###xml 299 307 298 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 574 582 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1205 1214 1204 1213 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1284 1285 1283 1284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1459 1460 1450 1451 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1214 1508 1213 1499 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">HMO2 binds preferentially to supercoiled DNA compared to linear DNA. (<bold>A</bold>) Reactions with 5 fmol of 50 bp looped DNA and 4 &#181;M HMO2. Lane 1, DNA only, lanes 2, 50 bp looped DNA and 4 &#181;M HMO2. Lanes 3&#8211;11 with 0.5&#8211;50 fmol supercoiled pGEM5. (<bold>B</bold>) Titration with linear pGEM5 with 5&#8242; overhangs.</p>
###xml 1214 1508 1213 1499 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">HMO2 binds preferentially to supercoiled DNA compared to linear DNA. (<bold>A</bold>) Reactions with 5 fmol of 50 bp looped DNA and 4 &#181;M HMO2. Lane 1, DNA only, lanes 2, 50 bp looped DNA and 4 &#181;M HMO2. Lanes 3&#8211;11 with 0.5&#8211;50 fmol supercoiled pGEM5. (<bold>B</bold>) Titration with linear pGEM5 with 5&#8242; overhangs.</p></caption>
###xml 1508 1508 1499 1499 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f3"/>
###xml 1205 1508 1204 1499 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="37">HMO2 binds preferentially to supercoiled DNA compared to linear DNA. (<bold>A</bold>) Reactions with 5 fmol of 50 bp looped DNA and 4 &#181;M HMO2. Lane 1, DNA only, lanes 2, 50 bp looped DNA and 4 &#181;M HMO2. Lanes 3&#8211;11 with 0.5&#8211;50 fmol supercoiled pGEM5. (<bold>B</bold>) Titration with linear pGEM5 with 5&#8242; overhangs.</p></caption><graphic xlink:href="gkp695f3"/></fig>
To ascertain whether HMO2 binds preferentially to supercoiled DNA, a competition assay was performed by incubating 5 fmol 50 bp looped DNA and 4 muM HMO2, following which 0.5-50 fmol of supercoiled or linearized pGEM5 was added to the reaction. Evidently, supercoiled DNA competes more efficiently (Figure 3); HMO2 forms a distinct complex with the looped DNA while supercoiled DNA competes as indicated by disappearance of the preformed complex. The linearized DNA does not compete at equivalent concentrations whether the DNA has 5' overhangs, 3' overhangs or blunt ends (Figure 3B and data not shown; note that the concentration of free DNA ends is at most 10 nM, well below the concentration of HMO2, while the concentration of internal sites would be more than two orders-of-magnitude higher, assuming a 20 bp site size). This suggests that HMO2 binds to supercoiled DNA with higher affinity compared to linearized DNA. Taken together, our data indicate that HMO2 resembles mammalian HMGB proteins in its preferred binding to supercoiled DNA or DNA with tandem mismatches, but that it distinguishes itself by its requirement for a longer DNA duplex and its preference for DNA with a pair of lesions. Figure 3.HMO2 binds preferentially to supercoiled DNA compared to linear DNA. (A) Reactions with 5 fmol of 50 bp looped DNA and 4 microM HMO2. Lane 1, DNA only, lanes 2, 50 bp looped DNA and 4 microM HMO2. Lanes 3-11 with 0.5-50 fmol supercoiled pGEM5. (B) Titration with linear pGEM5 with 5' overhangs.
###end p 36
###begin p 37
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 245 246 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
HMO2 binds preferentially to supercoiled DNA compared to linear DNA. (A) Reactions with 5 fmol of 50 bp looped DNA and 4 microM HMO2. Lane 1, DNA only, lanes 2, 50 bp looped DNA and 4 microM HMO2. Lanes 3-11 with 0.5-50 fmol supercoiled pGEM5. (B) Titration with linear pGEM5 with 5' overhangs.
###end p 37
###begin title 38
HMO2 binds DNA ends
###end title 38
###begin p 39
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 390 398 390 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 425 433 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 841 843 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1431 1439 1387 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1443 1452 1399 1408 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1501 1502 1457 1458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1544 1545 1500 1501 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1452 1829 1408 1761 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">HMO2 prevents ligation of DNA by T4 DNA ligase. (<bold>A</bold>) DNA with overhangs (5&#8242;-TA extensions). (<bold>B</bold>) DNA with blunt ends. Lanes 1, 100 ng of DNA (&#8764;4 nM, corresponding to &#8764;8 nM DNA ends). Lane 2, DNA and T4 DNA ligase. Lanes 3&#8211;8, DNA, T4 DNA ligase with 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. Lane 9, DNA, T4 DNA ligase, 4000 nM HMO2 and exonuclease III.</p>
###xml 1452 1829 1408 1761 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">HMO2 prevents ligation of DNA by T4 DNA ligase. (<bold>A</bold>) DNA with overhangs (5&#8242;-TA extensions). (<bold>B</bold>) DNA with blunt ends. Lanes 1, 100 ng of DNA (&#8764;4 nM, corresponding to &#8764;8 nM DNA ends). Lane 2, DNA and T4 DNA ligase. Lanes 3&#8211;8, DNA, T4 DNA ligase with 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. Lane 9, DNA, T4 DNA ligase, 4000 nM HMO2 and exonuclease III.</p></caption>
###xml 1829 1829 1761 1761 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f4"/>
###xml 1443 1829 1399 1761 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="40">HMO2 prevents ligation of DNA by T4 DNA ligase. (<bold>A</bold>) DNA with overhangs (5&#8242;-TA extensions). (<bold>B</bold>) DNA with blunt ends. Lanes 1, 100 ng of DNA (&#8764;4 nM, corresponding to &#8764;8 nM DNA ends). Lane 2, DNA and T4 DNA ligase. Lanes 3&#8211;8, DNA, T4 DNA ligase with 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. Lane 9, DNA, T4 DNA ligase, 4000 nM HMO2 and exonuclease III.</p></caption><graphic xlink:href="gkp695f4"/></fig>
HMGB proteins have been reported to promote DNA end-joining in vitro (26,27). The in vivo correlate would be that during DSB repair, HMGB might bring two DNA ends in closer proximity in preparation for either HR or NHEJ. HMO2, however, did not promote the formation of end-joined products in the presence of T4 DNA ligase. Instead, HMO2 prevented end-joining of DNA with a 5'-TA extension (Figure 4A) or DNA with blunt ends (Figure 4B). In Figure 4A and B, lane 2 shows 100 ng (approximately4 nM) linearized DNA ligated in presence of T4 DNA ligase. But in presence of HMO2 (0.1-4 microM; lanes 3-8) there are few if any end-joined products. By comparison, 100 ng plasmid DNA (approximately2 nM) may be efficiently ligated in the presence of mammalian HMGB1, with optimal ligation efficiency seen on addition of approximately1 microM HMGB1 (26). Notably, lane 9 suggests that the DNA is resistant to exonuclease III digestion in the presence of HMO2 and T4 DNA ligase. The failure to observe ligation products in presence of HMO2 as well as the inability of exonuclease III to digest the DNA suggests that HMO2 may be binding to the ends of the DNA duplex to prevent access to both T4 DNA ligase and exonuclease III. Also note that failure to join DNA ends is not due to HMO2 merely interacting with the ligase to prevent its activity, as evidenced by the activity of T4 DNA ligase on an internal DNA nick in the presence of HMO2 (Figure 1C). Figure 4.HMO2 prevents ligation of DNA by T4 DNA ligase. (A) DNA with overhangs (5'-TA extensions). (B) DNA with blunt ends. Lanes 1, 100 ng of DNA (approximately4 nM, corresponding to approximately8 nM DNA ends). Lane 2, DNA and T4 DNA ligase. Lanes 3-8, DNA, T4 DNA ligase with 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. Lane 9, DNA, T4 DNA ligase, 4000 nM HMO2 and exonuclease III.
###end p 39
###begin p 40
###xml 49 50 49 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
HMO2 prevents ligation of DNA by T4 DNA ligase. (A) DNA with overhangs (5'-TA extensions). (B) DNA with blunt ends. Lanes 1, 100 ng of DNA (approximately4 nM, corresponding to approximately8 nM DNA ends). Lane 2, DNA and T4 DNA ligase. Lanes 3-8, DNA, T4 DNA ligase with 100, 500, 1000, 2000, 3000 and 4000 nM HMO2. Lane 9, DNA, T4 DNA ligase, 4000 nM HMO2 and exonuclease III.
###end p 40
###begin p 41
###xml 103 111 103 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 585 593 585 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 595 603 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 788 796 788 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1300 1309 1300 1309 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1387 1388 1387 1388 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1707 1708 1683 1684 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1309 1943 1309 1907 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">HMO2 protects DNA with overhangs or blunt ends from exonucleolytic cleavage. (<bold>A</bold>) Lanes 1&#8211;4 and 5&#8211;8, DNA with 2-nt 5&#8242;-TA extensions (&#8764;4 nM) and blunt ends (&#8764;2 nM), respectively. Lanes 1 and 5, DNA only. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 4 and 8, DNA with 1000 nM HMO2 incubated with exonuclease III for 1 h. (<bold>B</bold>) DNA with 2-nt 3&#8242;-AT extensions (&#8764;4 nM). Lane 1, DNA only. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA with 2-nt 3&#8242; overhangs and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h.</p>
###xml 1309 1943 1309 1907 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">HMO2 protects DNA with overhangs or blunt ends from exonucleolytic cleavage. (<bold>A</bold>) Lanes 1&#8211;4 and 5&#8211;8, DNA with 2-nt 5&#8242;-TA extensions (&#8764;4 nM) and blunt ends (&#8764;2 nM), respectively. Lanes 1 and 5, DNA only. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 4 and 8, DNA with 1000 nM HMO2 incubated with exonuclease III for 1 h. (<bold>B</bold>) DNA with 2-nt 3&#8242;-AT extensions (&#8764;4 nM). Lane 1, DNA only. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA with 2-nt 3&#8242; overhangs and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h.</p></caption>
###xml 1943 1943 1907 1907 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f5"/>
###xml 1300 1943 1300 1907 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="42">HMO2 protects DNA with overhangs or blunt ends from exonucleolytic cleavage. (<bold>A</bold>) Lanes 1&#8211;4 and 5&#8211;8, DNA with 2-nt 5&#8242;-TA extensions (&#8764;4 nM) and blunt ends (&#8764;2 nM), respectively. Lanes 1 and 5, DNA only. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 4 and 8, DNA with 1000 nM HMO2 incubated with exonuclease III for 1 h. (<bold>B</bold>) DNA with 2-nt 3&#8242;-AT extensions (&#8764;4 nM). Lane 1, DNA only. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA with 2-nt 3&#8242; overhangs and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h.</p></caption><graphic xlink:href="gkp695f5"/></fig>
To examine further a potential DNA end-binding by HMO2, DNA with a 2-nt 5'-TA extension or blunt ends (Figure 5A) and DNA with a 2-nt 3'-AT extension (Figure 5B) was treated with exonuclease III in presence of HMO2. Exonuclease III reactions are terminated with SDS, and a control in which HMO2 is incubated with DNA in absence of exonuclease III is included (lane 3); in the latter reactions, the original DNA is quantitatively recovered upon treatment with SDS, indicating complete disruption of the HMO2-DNA complex, which would otherwise be manifest as a mobility shift as seen in Figure 1. Figure 5A, lanes 2 and 6 and Figure 5B, lane 2, shows DNA with 5' overhangs, blunt ends and 3' overhangs digested extensively by exonuclease III. But in presence of HMO2, the DNA is protected (Figure 5A, lanes 4 and 8; B, lane 4). Since HMO2 obviously prevents the formation of partial digestion products, as it prevents the more extensive digestion seen on prolonged incubation with exonuclease III, we elected to show only the time-point at which exonuclease III has digested unprotected DNA to such an extent that no individual bands are discernible. These data suggest that HMO2 may be binding to both DNA with 5' and 3' overhangs or blunt ends and preventing exonuclease III from accessing the ends. Figure 5.HMO2 protects DNA with overhangs or blunt ends from exonucleolytic cleavage. (A) Lanes 1-4 and 5-8, DNA with 2-nt 5'-TA extensions (approximately4 nM) and blunt ends (approximately2 nM), respectively. Lanes 1 and 5, DNA only. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 4 and 8, DNA with 1000 nM HMO2 incubated with exonuclease III for 1 h. (B) DNA with 2-nt 3'-AT extensions (approximately4 nM). Lane 1, DNA only. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA with 2-nt 3' overhangs and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h.
###end p 41
###begin p 42
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 398 399 374 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
HMO2 protects DNA with overhangs or blunt ends from exonucleolytic cleavage. (A) Lanes 1-4 and 5-8, DNA with 2-nt 5'-TA extensions (approximately4 nM) and blunt ends (approximately2 nM), respectively. Lanes 1 and 5, DNA only. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 4 and 8, DNA with 1000 nM HMO2 incubated with exonuclease III for 1 h. (B) DNA with 2-nt 3'-AT extensions (approximately4 nM). Lane 1, DNA only. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA with 2-nt 3' overhangs and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h.
###end p 42
###begin p 43
###xml 206 214 206 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 762 770 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1011 1019 1011 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1540 1548 1540 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1824 1833 1824 1833 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1910 1911 1910 1911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2431 2432 2407 2408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2592 2593 2552 2553 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2818 2819 2778 2779 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3062 3073 3022 3033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. subtilis</italic>
###xml 3127 3138 3087 3098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. subtilis</italic>
###xml 1833 3230 1833 3190 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">DNA protection by HMO2 depends on DNA length and sequence of DNA overhangs. (<bold>A</bold>) DNA with G+C-containing overhangs is not protected by HMO2. Lanes 1&#8211;4, DNA with 5&#8242;-CATG extensions (&#8764;2 nM), lanes 5&#8211;8, DNA with 5&#8242;-TA extensions (&#8764;4 nM). Lanes 1 and 5, DNA only. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 4 and 8, DNA with 2000 nM HMO2 incubated with exonuclease III for 1 h. Note in lane 8 the appearance of a product with lower mobility. Only the two largest fragments of BspHI-digested pET5a are shown in lanes 1&#8211;4. (<bold>B</bold>) Ligation of DNA with 5&#8242;-CATG extension (&#8764;2 nM). Lane 1, DNA only. Lane 2, DNA and T4 DNA ligase. Lane 3, DNA, T4 DNA ligase and 2.5 &#181;M HMO2. (<bold>C</bold>) Length dependence of DNA protection by HMO2. Lane 1, DNA with 4-nt 5&#8242; overhangs. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h. (<bold>D</bold>) HMO2 can end-join 105 bp DNA in presence of T4 DNA ligase. Lane 1, 100 fmol of 105 bp DNA. Lane 2, 105 bp DNA and T4 DNA ligase. Lanes 3&#8211;5, 105 bp DNA, T4 DNA ligase and 100, 250 and 500 nM HMO2. Lane 6, 105 bp DNA, T4 DNA ligase and 100 nM <italic>B. subtilis</italic> HU (HBsu). Lane 7, 105 bp DNA, T4 DNA ligase, 100 nM <italic>B. subtilis</italic> HU and exonuclease III. Lane 8, 105 bp DNA, T4 DNA ligase, 250 nM HMO2 and exonuclease III.</p>
###xml 1833 3230 1833 3190 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">DNA protection by HMO2 depends on DNA length and sequence of DNA overhangs. (<bold>A</bold>) DNA with G+C-containing overhangs is not protected by HMO2. Lanes 1&#8211;4, DNA with 5&#8242;-CATG extensions (&#8764;2 nM), lanes 5&#8211;8, DNA with 5&#8242;-TA extensions (&#8764;4 nM). Lanes 1 and 5, DNA only. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 4 and 8, DNA with 2000 nM HMO2 incubated with exonuclease III for 1 h. Note in lane 8 the appearance of a product with lower mobility. Only the two largest fragments of BspHI-digested pET5a are shown in lanes 1&#8211;4. (<bold>B</bold>) Ligation of DNA with 5&#8242;-CATG extension (&#8764;2 nM). Lane 1, DNA only. Lane 2, DNA and T4 DNA ligase. Lane 3, DNA, T4 DNA ligase and 2.5 &#181;M HMO2. (<bold>C</bold>) Length dependence of DNA protection by HMO2. Lane 1, DNA with 4-nt 5&#8242; overhangs. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h. (<bold>D</bold>) HMO2 can end-join 105 bp DNA in presence of T4 DNA ligase. Lane 1, 100 fmol of 105 bp DNA. Lane 2, 105 bp DNA and T4 DNA ligase. Lanes 3&#8211;5, 105 bp DNA, T4 DNA ligase and 100, 250 and 500 nM HMO2. Lane 6, 105 bp DNA, T4 DNA ligase and 100 nM <italic>B. subtilis</italic> HU (HBsu). Lane 7, 105 bp DNA, T4 DNA ligase, 100 nM <italic>B. subtilis</italic> HU and exonuclease III. Lane 8, 105 bp DNA, T4 DNA ligase, 250 nM HMO2 and exonuclease III.</p></caption>
###xml 3230 3230 3190 3190 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f6"/>
###xml 1824 3230 1824 3190 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="44">DNA protection by HMO2 depends on DNA length and sequence of DNA overhangs. (<bold>A</bold>) DNA with G+C-containing overhangs is not protected by HMO2. Lanes 1&#8211;4, DNA with 5&#8242;-CATG extensions (&#8764;2 nM), lanes 5&#8211;8, DNA with 5&#8242;-TA extensions (&#8764;4 nM). Lanes 1 and 5, DNA only. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 4 and 8, DNA with 2000 nM HMO2 incubated with exonuclease III for 1 h. Note in lane 8 the appearance of a product with lower mobility. Only the two largest fragments of BspHI-digested pET5a are shown in lanes 1&#8211;4. (<bold>B</bold>) Ligation of DNA with 5&#8242;-CATG extension (&#8764;2 nM). Lane 1, DNA only. Lane 2, DNA and T4 DNA ligase. Lane 3, DNA, T4 DNA ligase and 2.5 &#181;M HMO2. (<bold>C</bold>) Length dependence of DNA protection by HMO2. Lane 1, DNA with 4-nt 5&#8242; overhangs. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h. (<bold>D</bold>) HMO2 can end-join 105 bp DNA in presence of T4 DNA ligase. Lane 1, 100 fmol of 105 bp DNA. Lane 2, 105 bp DNA and T4 DNA ligase. Lanes 3&#8211;5, 105 bp DNA, T4 DNA ligase and 100, 250 and 500 nM HMO2. Lane 6, 105 bp DNA, T4 DNA ligase and 100 nM <italic>B. subtilis</italic> HU (HBsu). Lane 7, 105 bp DNA, T4 DNA ligase, 100 nM <italic>B. subtilis</italic> HU and exonuclease III. Lane 8, 105 bp DNA, T4 DNA ligase, 250 nM HMO2 and exonuclease III.</p></caption><graphic xlink:href="gkp695f6"/></fig>
###xml 3062 3073 <span type="species:ncbi:1423">B. subtilis</span>
###xml 3127 3138 <span type="species:ncbi:1423">B. subtilis</span>
If HMO2 binds stably to DNA ends, preventing access of both T4 DNA ligase and exonuclease III, then the expectation would have been for stable complex formation with 50 bp DNA duplex. This is not observed (Figure 2A). Furthermore, we do not observe protection of 50 bp DNA from exonuclease III-digestion in the presence of HMO2 (data not shown). We therefore considered that the 50 bp DNA might be too short to accommodate HMO2 stably at both ends simultaneously. To address this question, plasmid DNA was digested with assorted enzymes to yield fragments of different sizes. When plasmid pET5a is digested with BspHI, four fragments are produced that contain 5'-CATG extensions. However, when incubated with HMO2 and exonuclease III, no protection is observed (Figure 6A, lane 4), while DNA with 5'-TA extension is protected from exonucleolytic digestion (lane 8). Consistent with the inability of HMO2 to protect DNA with BspHI-generated 5' overhangs, such DNA may be re-ligated in presence of T4 DNA ligase (Figure 6B, lane 3; lanes 1 and 2 contain DNA without and with T4 DNA ligase, respectively). That ligation products obtained in the presence of HMO2 migrate differently compared to those created in its absence may suggest either that HMO2 still binds with sufficient affinity to the 5'-CATG overhangs to compete with ligase for binding or that binding to internal sites results in a DNA conformation that favors formation of a different population of ligation products. Since DNA with 5'-AATT extensions is efficiently protected (Figure 6C), our data suggest that it is the sequence of the overhangs that affects HMO2 binding. The differential protection of DNA of comparable length, but with distinct sequence of the single-stranded overhang, clearly indicates that HMO2 recognizes specific features of DNA ends. Figure 6.DNA protection by HMO2 depends on DNA length and sequence of DNA overhangs. (A) DNA with G+C-containing overhangs is not protected by HMO2. Lanes 1-4, DNA with 5'-CATG extensions (approximately2 nM), lanes 5-8, DNA with 5'-TA extensions (approximately4 nM). Lanes 1 and 5, DNA only. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 4 and 8, DNA with 2000 nM HMO2 incubated with exonuclease III for 1 h. Note in lane 8 the appearance of a product with lower mobility. Only the two largest fragments of BspHI-digested pET5a are shown in lanes 1-4. (B) Ligation of DNA with 5'-CATG extension (approximately2 nM). Lane 1, DNA only. Lane 2, DNA and T4 DNA ligase. Lane 3, DNA, T4 DNA ligase and 2.5 microM HMO2. (C) Length dependence of DNA protection by HMO2. Lane 1, DNA with 4-nt 5' overhangs. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h. (D) HMO2 can end-join 105 bp DNA in presence of T4 DNA ligase. Lane 1, 100 fmol of 105 bp DNA. Lane 2, 105 bp DNA and T4 DNA ligase. Lanes 3-5, 105 bp DNA, T4 DNA ligase and 100, 250 and 500 nM HMO2. Lane 6, 105 bp DNA, T4 DNA ligase and 100 nM B. subtilis HU (HBsu). Lane 7, 105 bp DNA, T4 DNA ligase, 100 nM B. subtilis HU and exonuclease III. Lane 8, 105 bp DNA, T4 DNA ligase, 250 nM HMO2 and exonuclease III.
###end p 43
###begin p 44
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 598 599 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 759 760 719 720 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 985 986 945 946 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1229 1240 1189 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. subtilis</italic>
###xml 1294 1305 1254 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. subtilis</italic>
###xml 1229 1240 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1294 1305 <span type="species:ncbi:1423">B. subtilis</span>
DNA protection by HMO2 depends on DNA length and sequence of DNA overhangs. (A) DNA with G+C-containing overhangs is not protected by HMO2. Lanes 1-4, DNA with 5'-CATG extensions (approximately2 nM), lanes 5-8, DNA with 5'-TA extensions (approximately4 nM). Lanes 1 and 5, DNA only. Lanes 2 and 6, DNA treated with exonuclease III for 1 h. Lanes 3 and 7, DNA and 2000 nM HMO2. Lanes 4 and 8, DNA with 2000 nM HMO2 incubated with exonuclease III for 1 h. Note in lane 8 the appearance of a product with lower mobility. Only the two largest fragments of BspHI-digested pET5a are shown in lanes 1-4. (B) Ligation of DNA with 5'-CATG extension (approximately2 nM). Lane 1, DNA only. Lane 2, DNA and T4 DNA ligase. Lane 3, DNA, T4 DNA ligase and 2.5 microM HMO2. (C) Length dependence of DNA protection by HMO2. Lane 1, DNA with 4-nt 5' overhangs. Lane 2, DNA treated with exonuclease III for 1 h. Lane 3, DNA and 2000 nM HMO2. Lane 4, DNA incubated with HMO2 and exonuclease III for 1 h. (D) HMO2 can end-join 105 bp DNA in presence of T4 DNA ligase. Lane 1, 100 fmol of 105 bp DNA. Lane 2, 105 bp DNA and T4 DNA ligase. Lanes 3-5, 105 bp DNA, T4 DNA ligase and 100, 250 and 500 nM HMO2. Lane 6, 105 bp DNA, T4 DNA ligase and 100 nM B. subtilis HU (HBsu). Lane 7, 105 bp DNA, T4 DNA ligase, 100 nM B. subtilis HU and exonuclease III. Lane 8, 105 bp DNA, T4 DNA ligase, 250 nM HMO2 and exonuclease III.
###end p 44
###begin p 45
###xml 277 285 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
To determine the DNA length required for efficient protection by HMO2, we therefore used enzymes that produce blunt ends or A+T-containing overhangs. A pCDNA3-derivative when linearized with ApoI produces the following sizes of DNA, 127, 187, 811, 848, 1444, 1475 and 2277 bp. Figure 6C, lane 4 shows that HMO2 could efficiently protect 811, 848, 1444, 1475 and 2277 bp but was unable to protect 127 and 187 bp DNA, indicating that a suitable size of the DNA is important for HMO2 in order to protect it from exonucleolytic cleavage. Consistent with this observation, HMO2 was able to protect 339, 692 and 713 bp fragments of pRAD1 linearized with DraI (data not shown). This suggests that not only the size of the DNA but also the sequence of the DNA overhang is important for HMO2 to bind and protect the DNA.
###end p 45
###begin p 46
###xml 297 305 297 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 417 428 417 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. subtilis</italic>
###xml 417 428 <span type="species:ncbi:1423">B. subtilis</span>
The failure to protect short DNA from exonuclease III digestion, even if single-stranded overhangs are otherwise compatible with HMO2-binding, predicts that such duplexes should be ligatable in presence of HMO2. We therefore performed an end-joining assay using 105 bp DNA with 5'-AATT overhangs. Figure 6D shows that HMO2 promotes DNA dimer formation in presence of T4 DNA ligase (lanes 3-5). Similar reactions with B. subtilis HU indicate formation of monomer circle, as evidenced by its protection from exonuclease III digestion (lanes 6 and 7). Lane 8 indicates that ligation products with 105 bp obtained in presence of HMO2 cannot be protected from exonuclease III. This experiment not only confirms the inability of HMO2 to associate with the ends of short DNA in a manner that prevents access to ligase and exonuclease III, but it also reveals that HMO2 does not promote cyclization of short DNA. Whether this reflects an inability of HMO2 to bend DNA, the association of several HMO2 protomers causing out-of-phase bending, or preferred binding to DNA ends remains to be determined.
###end p 46
###begin p 47
###xml 326 334 326 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 751 760 751 760 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 760 1386 760 1374 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">HMO2 does not protect supercoiled or linearized DNA from endonucleolytic cleavage. Lanes 1&#8211;6, 7&#8211;12 and 13&#8211;18, supercoiled DNA, DNA with overhangs and DNA with blunt ends, respectively (&#8764;4 nM). Lanes 1, 7 and 13, DNA only. Lanes 3, 9 and 15, DNA and 1000 nM HMO2. Lanes 2, 8 and 14, DNA treated with DNase I for 2.5 min. Lanes 4, 5 and 6, supercoiled DNA and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 10, 11 and 12, DNA with overhangs and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 16, 17 and 18, DNA with blunt ends and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min.</p>
###xml 760 1386 760 1374 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">HMO2 does not protect supercoiled or linearized DNA from endonucleolytic cleavage. Lanes 1&#8211;6, 7&#8211;12 and 13&#8211;18, supercoiled DNA, DNA with overhangs and DNA with blunt ends, respectively (&#8764;4 nM). Lanes 1, 7 and 13, DNA only. Lanes 3, 9 and 15, DNA and 1000 nM HMO2. Lanes 2, 8 and 14, DNA treated with DNase I for 2.5 min. Lanes 4, 5 and 6, supercoiled DNA and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 10, 11 and 12, DNA with overhangs and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 16, 17 and 18, DNA with blunt ends and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min.</p></caption>
###xml 1386 1386 1374 1374 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f7"/>
###xml 751 1386 751 1374 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="48">HMO2 does not protect supercoiled or linearized DNA from endonucleolytic cleavage. Lanes 1&#8211;6, 7&#8211;12 and 13&#8211;18, supercoiled DNA, DNA with overhangs and DNA with blunt ends, respectively (&#8764;4 nM). Lanes 1, 7 and 13, DNA only. Lanes 3, 9 and 15, DNA and 1000 nM HMO2. Lanes 2, 8 and 14, DNA treated with DNase I for 2.5 min. Lanes 4, 5 and 6, supercoiled DNA and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 10, 11 and 12, DNA with overhangs and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 16, 17 and 18, DNA with blunt ends and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min.</p></caption><graphic xlink:href="gkp695f7"/></fig>
To rule out the possibility that HMO2 may coat or compact the entire DNA, thereby rendering the majority of the DNA resistant to exonuclease digestion, we assessed whether HMO2-DNA complexes are also resistant to endonucleolytic digestion. Supercoiled DNA or linear DNA with overhangs or blunt ends were treated with DNase I. Figure 7, lanes 2, 8 and 14 show DNA treated with DNaseI wherein the DNA is digested extensively. In presence of HMO2, DNaseI is likewise able to digest the DNA (lanes 4-6, 10-12 and 16-18). The inability of HMO2 to attenuate endonucleolytic digestion is consistent with the interpretation that protection against exonuclease III-mediated digestion is due to end-binding by HMO2, not continuous protection of internal sites. Figure 7.HMO2 does not protect supercoiled or linearized DNA from endonucleolytic cleavage. Lanes 1-6, 7-12 and 13-18, supercoiled DNA, DNA with overhangs and DNA with blunt ends, respectively (approximately4 nM). Lanes 1, 7 and 13, DNA only. Lanes 3, 9 and 15, DNA and 1000 nM HMO2. Lanes 2, 8 and 14, DNA treated with DNase I for 2.5 min. Lanes 4, 5 and 6, supercoiled DNA and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 10, 11 and 12, DNA with overhangs and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 16, 17 and 18, DNA with blunt ends and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min.
###end p 47
###begin p 48
HMO2 does not protect supercoiled or linearized DNA from endonucleolytic cleavage. Lanes 1-6, 7-12 and 13-18, supercoiled DNA, DNA with overhangs and DNA with blunt ends, respectively (approximately4 nM). Lanes 1, 7 and 13, DNA only. Lanes 3, 9 and 15, DNA and 1000 nM HMO2. Lanes 2, 8 and 14, DNA treated with DNase I for 2.5 min. Lanes 4, 5 and 6, supercoiled DNA and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 10, 11 and 12, DNA with overhangs and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min. Lanes 16, 17 and 18, DNA with blunt ends and 1000 nM HMO2 treated with DNase I for 1, 2.5 and 5 min.
###end p 48
###begin p 49
###xml 215 223 215 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 597 605 597 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 620 629 620 629 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 716 717 716 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 947 948 947 948 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 629 1190 629 1190 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">HMO1 promotes DNA end-joining, but does not protect DNA from exonucleolytic cleavage. (<bold>A</bold>) HMO1 can promote end-joining of pGEM5 DNA with 2-nt 5&#8242; overhang in presence of T4 DNA ligase. Lane 1, 100 ng DNA only. Lane 2, DNA and T4 DNA ligase. Lanes 3&#8211;5, DNA, T4 DNA ligase, and 500, 1000 and 2000 nM HMO1, respectively. (<bold>B</bold>) HMO1 is unable to protect DNA with 2-nt 5&#8242; overhangs from exonuclease III. Lane 1, 100 ng DNA only. Lane 2, DNA and exonuclease III. Lane 3, DNA and 500 nM HMO1. Lanes 4&#8211;6, DNA, exonuclease III, and 500, 1000 and 2000 nM HMO1, respectively.</p>
###xml 629 1190 629 1190 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">HMO1 promotes DNA end-joining, but does not protect DNA from exonucleolytic cleavage. (<bold>A</bold>) HMO1 can promote end-joining of pGEM5 DNA with 2-nt 5&#8242; overhang in presence of T4 DNA ligase. Lane 1, 100 ng DNA only. Lane 2, DNA and T4 DNA ligase. Lanes 3&#8211;5, DNA, T4 DNA ligase, and 500, 1000 and 2000 nM HMO1, respectively. (<bold>B</bold>) HMO1 is unable to protect DNA with 2-nt 5&#8242; overhangs from exonuclease III. Lane 1, 100 ng DNA only. Lane 2, DNA and exonuclease III. Lane 3, DNA and 500 nM HMO1. Lanes 4&#8211;6, DNA, exonuclease III, and 500, 1000 and 2000 nM HMO1, respectively.</p></caption>
###xml 1190 1190 1190 1190 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp695f8"/>
###xml 620 1190 620 1190 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="50">HMO1 promotes DNA end-joining, but does not protect DNA from exonucleolytic cleavage. (<bold>A</bold>) HMO1 can promote end-joining of pGEM5 DNA with 2-nt 5&#8242; overhang in presence of T4 DNA ligase. Lane 1, 100 ng DNA only. Lane 2, DNA and T4 DNA ligase. Lanes 3&#8211;5, DNA, T4 DNA ligase, and 500, 1000 and 2000 nM HMO1, respectively. (<bold>B</bold>) HMO1 is unable to protect DNA with 2-nt 5&#8242; overhangs from exonuclease III. Lane 1, 100 ng DNA only. Lane 2, DNA and exonuclease III. Lane 3, DNA and 500 nM HMO1. Lanes 4&#8211;6, DNA, exonuclease III, and 500, 1000 and 2000 nM HMO1, respectively.</p></caption><graphic xlink:href="gkp695f8"/></fig>
###xml 136 141 <span type="species:ncbi:4932">yeast</span>
To document further that the very stable binding to DNA ends that is characteristic of HMO2 is unique and not a general property of the yeast HMGB proteins, we performed the equivalent assays with HMO1. As shown in Figure 8, properties of HMO1 are more akin to those of mammalian HMGB1; it does promote the association of DNA ends in the presence of DNA ligase (Figure 8A), but it either does not bind to DNA ends or does so only transiently to allow efficient access to exonuclease III, as evidenced by its failure to protect linearized pGEM5 with 2-nt 5' overhangs from exonucleolytic cleavage (Figure 8B, lanes 4-6). Figure 8.HMO1 promotes DNA end-joining, but does not protect DNA from exonucleolytic cleavage. (A) HMO1 can promote end-joining of pGEM5 DNA with 2-nt 5' overhang in presence of T4 DNA ligase. Lane 1, 100 ng DNA only. Lane 2, DNA and T4 DNA ligase. Lanes 3-5, DNA, T4 DNA ligase, and 500, 1000 and 2000 nM HMO1, respectively. (B) HMO1 is unable to protect DNA with 2-nt 5' overhangs from exonuclease III. Lane 1, 100 ng DNA only. Lane 2, DNA and exonuclease III. Lane 3, DNA and 500 nM HMO1. Lanes 4-6, DNA, exonuclease III, and 500, 1000 and 2000 nM HMO1, respectively.
###end p 49
###begin p 50
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
HMO1 promotes DNA end-joining, but does not protect DNA from exonucleolytic cleavage. (A) HMO1 can promote end-joining of pGEM5 DNA with 2-nt 5' overhang in presence of T4 DNA ligase. Lane 1, 100 ng DNA only. Lane 2, DNA and T4 DNA ligase. Lanes 3-5, DNA, T4 DNA ligase, and 500, 1000 and 2000 nM HMO1, respectively. (B) HMO1 is unable to protect DNA with 2-nt 5' overhangs from exonuclease III. Lane 1, 100 ng DNA only. Lane 2, DNA and exonuclease III. Lane 3, DNA and 500 nM HMO1. Lanes 4-6, DNA, exonuclease III, and 500, 1000 and 2000 nM HMO1, respectively.
###end p 50
###begin title 51
DISCUSSION
###end title 51
###begin title 52
Preferential binding to distorted DNA
###end title 52
###begin p 53
###xml 68 73 56 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19 B20 B21 B22 B23">19&#8211;23</xref>
###xml 340 342 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 492 500 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 193 198 <span type="species:ncbi:4932">yeast</span>
The occluded DNA site size for an HMG domain is approximately10 bp (19-23). Since HMO2 has two domains, Box A and Box B, it would be predicted to require at least a 20 bp DNA site; indeed, the yeast HMGB homolog HMO1, which also features two HMG-like domains, binds poorly to 18 bp DNA, but with significantly higher affinity to 26 bp DNA (37). However, our data suggest that HMO2 binds only weakly to 37 bp DNA with loops (data not shown) and with much greater affinity to 50 bp looped DNA (Figure 2). For the Box B domain, which has high homology to mammalian HMGB proteins, interaction with a 10 bp site is a strong prediction. Although the Box A domain differs from consensus HMG sequences, its similarity to the HMO1 Box A domain, which also differs from consensus sequences, yet interacts with an approximately10 bp site, likewise predicts an approximately10 bp site. Based on these assumptions about the site sizes for Box A and Box B, a 50 bp DNA construct would be of sufficient length to accommodate a dimer; this interpretation does not necessarily imply that HMO2 likewise binds perfect duplex DNA as a dimer, as the loops may potentially impose a constraint, such as preferred binding to the 4-nt loop by only one of the two protein domains.
###end p 53
###begin p 54
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 335 340 335 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42 B43 B44">42&#8211;44</xref>
###xml 433 441 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
HMGB proteins have been previously shown to bind DNA with loops (40,45). The binding preference for DNA with flexure points is a functional correlate of the DNA bend introduced on interaction with an HMG domain, and the prediction is that HMO2 likewise bends its DNA site. HMGB proteins also bind preferably to four-way DNA junctions (42-44); while HMO2 does bind four-way DNA junctions in preference to a linear DNA duplex (compare Figure 2A and E), the preference is modest. For mammalian HMGB1, binding to four-way DNA junctions is mediated by the Box A domain (44). This selectivity arises from using a hydrophobic residue from helix II of the HMG fold as a bending wedge; the greater preference for distorted DNA is due to stacking of this residue on an exposed base pair. In contrast, mammalian HMGB1 Box B has bending wedges in both helices I and II of the HMG fold and is primarily responsible for DNA bending, whereas its affinity for distorted DNA is only modestly higher than that for perfect duplex DNA. By comparison, HMO2 is also predicted to feature a bending wedge (Leu) in helix II of its Box A domain, suggesting that this domain contributes the binding preference for distorted DNA. For HMO2 Box B, a leucine in helix I would be predicted to be the DNA intercalating residue.
###end p 54
###begin p 55
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 526 534 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
Like other HMGB proteins, HMO2 binds preferentially to supercoiled DNA compared to linear DNA (Figures 1 and 3). The DNA-protein complex with highest [HMO2] migrates faster in the gel (Figure 1, lanes 6 and 7), suggesting that HMO2 might play a role in DNA compaction. This observation is consistent with the ability of HMO2 to introduce supercoils and with the enhanced staining of HMO2-bound DNA by ethidium bromide that may also reflect DNA unwinding by HMO2. While nuclear HMGB proteins have not been shown to compact DNA in vitro as determined by changes in electrophoretic mobility, Abf2p, a protein closely related to the HMG family, has been shown to compact mitochondrial DNA (46). Long-range DNA looping created by protein-protein contacts, however, has been shown to produce more compact DNA structures (47).
###end p 55
###begin title 56
DNA-end binding
###end title 56
###begin p 57
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Consistent with its preferred binding to negatively supercoiled DNA, HMO2 produces DNA supercoils, due either to DNA underwinding or out-of-plane bending. And as noted above, its preferred binding to DNA loops likely reflects the energetic advantage to bending DNA with flexible joints. In these interactions, HMO2 emulates properties of mammalian HMGB homologs. What is unique about HMO2 is its remarkable ability to protect certain DNA constructs from exonucleolytic cleavage and to prevent their end-joining in presence of T4 DNA ligase, suggesting preferred binding to these DNA ends. DNA with blunt ends is protected efficiently, while in case of DNA with overhangs, the sequence of the single stranded overhang significantly affects HMO2 binding (Figures 5A, B, and 6A). Considering the preferred binding of HMO2 to distorted DNA sites, its interaction with DNA ends may likewise be a manifestation of preferred binding to more deformable duplex regions. Mammalian HMGB1 has been reported to bind DNA ends, but not to protect DNA ends from exonuclease III, perhaps reflecting a more dynamic association with the DNA ends (26). The ability of HMO2 to associate more stably with DNA ends is perhaps attributable to the divergent Box A domain which bears little resemblance to mammalian Box A.
###end p 57
###begin p 58
###xml 84 92 84 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 518 523 <span type="species:ncbi:4932">yeast</span>
It is also evident that HMO2 requires DNA of a suitable length to bind and protect (Figure 6C). Since HMO2 forms stable complex with plasmid DNA, but not with 50 bp perfect duplex, and since it appears to bind only as a dimer to 50 bp looped DNA, complex stability is likely a consequence of both DNA structure and protein-protein interactions. Such interactions are likely the reason for protection only of DNA long enough for assembly of several protomers at each DNA end. Self-association was also reported for the yeast HMGB homolog HMO1 as well as for mammalian HMGB1, for which residues in the box B domain critical for its ability to stimulate DNA end-joining were also important for box B self-association on supercoiled DNA and the formation of large nucleoprotein complexes (26,31,37).
###end p 58
###begin p 59
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 556 564 556 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 653 661 653 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1447 1449 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1659 1661 1659 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
If HMO2 were to protect DNA from exonuclease III digestion largely by occluding essentially the entire DNA, except for a limited number of base pairs at the ends, then protection from endonuclease digestion might also be seen. However, no such protection is observed (Figure 7). For this interpretation to be considered, one would also expect that all DNA fragments, regardless of sequence of the DNA overhangs, would be protected comparably. This is also not observed, as evidenced by the failure of HMO2 to protect DNA with C- or G-containing overhangs (Figure 6A and B). We also note that ligation at an internal nick occurs in the presence of HMO2 (Figure 1C). For HMO2 to bend internal sites, thereby restricting access to exonuclease III and DNA ligase is likewise unlikely; first, attenuated access to endonuclease would again be expected, as would protection of DNA fragments regardless of sequence of DNA overhangs. If significant out-of-phase bending occurred upon HMO2 binding, this could stiffen DNA and prevent net DNA bending, resulting in preferential generation of linear ligation products in preference to circular products, an effect likely to be most pronounced using shorter DNA fragments as opposed to plasmid DNA. Indeed, facilitated cyclization of short DNA fragments in presence of a DNA-bending protein is commonly used as an assay for DNA bending, without internal DNA bends restricting access of DNA ligase to DNA ends (27,37). In-phase bending might lead to compaction; such compacted DNA may be produced by both HMGB homologs and the bacterial histone-like HU proteins, again without restricting access of DNA ends to DNA ligase (48). Based on these observations and considerations, we therefore conclude that HMO2 exerts its protection against exonuclease III by binding to the DNA ends.
###end p 59
###begin p 60
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 355 363 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 825 833 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
If DNA with complementary overhangs were to anneal, a duplex with nicks would be produced. However, it can also be ruled out that HMO2 merely binds preferentially to such nicked DNA constructs to prevent their ligation, as short DNA with equivalent overhangs may be ligated (Figure 6D). Nicked plasmid DNA may likewise be ligated in the presence of HMO2 (Figure 1C). Indeed, the enhanced ligation of 105 bp DNA in the presence of HMO2 suggests that HMO2 may also bind the ends of the shorter DNA, albeit less stably, as reflected in its inability to protect such duplexes from exonucleolytic digestion. That HMO2 promotes DNA end-joining in the presence of DNA ligase may also be related to the occasional appearance of more slowly migrating DNA species following incubation of linear DNA with both HMO2 and exonuclease III (Figure 6A, lane 8); since these reactions are deproteinized and no ligase is present, we surmise that long single-stranded overhangs generated by exonuclease may invade a complementary duplex in presence of HMO2 to generate a merged structure that is stable to the subsequent manipulations. This possibility is currently under investigation.
###end p 60
###begin p 61
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1470 1472 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 285 290 <span type="species:ncbi:4932">yeast</span>
###xml 1335 1340 <span type="species:ncbi:4932">yeast</span>
Recently, HMO2 was reported to be a part of the ATP-dependent chromatin-remodeling complex INO80 and to be important for recruitment of the INO80 complex to a DSB (3). Arrival of the INO80 complex is predicted to be a part of the early response to DSB formation. In both mammalian and yeast cells, a complex containing the Ku heterodimer and DNA ligase is capable of rejoining DNA DSBs with compatible ends via NHEJ, while DNA with damaged ends requires additional factors (2,4). Furthermore, NHEJ and HR events interfere with each other; for example, a Rad51 filament forms on single-stranded DNA in preparation for HR and impedes NHEJ (49). It is conceivable, therefore, that HMO2, in addition to its role in INO80 recruitment, also contributes to the protection of DNA ends that is essential to preserve the genetic information before DSB repair can be completed. In its complex with INO80 components, HMO2 was reported to interact with phosphorylated histone H2A, indicating that it is not buried in the complex, but accessible for interaction with chromatin. It is therefore likely that it would also be accessible for binding to naked DNA. The preferred binding to DNA with blunt ends or with A+T-containing overhangs may indicate differential functions depending on the type of DNA ends and the DNA repair pathway; for example, yeast Rad51 binds more slowly to single-stranded DNA with AT dinucleotide repeats compared to C- or G-containing dinucleotide repeats (50), perhaps requiring accessory proteins to protect such A+T-rich sequences.
###end p 61
###begin title 62
SUPPLEMENTARY DATA
###end title 62
###begin p 63
 are available at NAR Online.
###end p 63
###begin title 64
[Supplementary Data]
###end title 64
###begin title 65
FUNDING
###end title 65
###begin p 66
National Science Foundation [MCB-0414875 and MCB-0744240 to A.G.].
###end p 66
###begin p 67
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 67
###begin title 68
ACKNOWLEDGMENTS
###end title 68
###begin p 69
The authors thank Dr LiJuan Xiao for providing HMO1.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin article-title 71
ATP-dependent chromatin remodeling and DNA double-strand break repair
###end article-title 71
###begin article-title 72
Differential usage of non-homologous end-joining and homologous recombination in double strand break repair
###end article-title 72
###begin article-title 73
INO80 and gamma-H2AX interaction links ATP dependent chromatin remodeling to DNA damage repair
###end article-title 73
###begin article-title 74
###xml 70 94 70 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 70 94 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae
###end article-title 74
###begin article-title 75
Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair
###end article-title 75
###begin article-title 76
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair
###end article-title 76
###begin article-title 77
###xml 66 71 <span type="species:ncbi:4932">yeast</span>
A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex
###end article-title 77
###begin article-title 78
A chromatin remodelling complex involved in transcription and DNA processing
###end article-title 78
###begin article-title 79
Involvement of actin-related proteins in ATP-dependent chromatin remodeling
###end article-title 79
###begin article-title 80
Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair
###end article-title 80
###begin article-title 81
Distinct roles for SWR1 and INO80 chromatin remodeling complexes at chromosomal double-strand breaks
###end article-title 81
###begin article-title 82
Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins
###end article-title 82
###begin article-title 83
Revised nomenclature for high mobility group (HMG) chromosomal proteins
###end article-title 83
###begin article-title 84
###xml 41 65 41 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 41 65 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A
###end article-title 84
###begin article-title 85
LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]
###end article-title 85
###begin article-title 86
###xml 16 21 <span type="species:ncbi:9606">human</span>
A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif
###end article-title 86
###begin article-title 87
Structural basis for DNA bending by the architectural transcription factor LEF-1
###end article-title 87
###begin article-title 88
###xml 53 58 <span type="species:ncbi:4932">yeast</span>
Chromatin-mediated transcriptional regulation by the yeast architectural factors NHP6A and NHP6B
###end article-title 88
###begin article-title 89
Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding
###end article-title 89
###begin article-title 90
Structure of a complex of tandem HMG boxes and DNA
###end article-title 90
###begin article-title 91
The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity
###end article-title 91
###begin article-title 92
Nature of full-length HMGB1 binding to cisplatin-modified DNA
###end article-title 92
###begin article-title 93
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
###end article-title 93
###begin article-title 94
Nucleosome linker proteins HMGB1 and histone H1 differentially enhance DNA ligation reactions
###end article-title 94
###begin article-title 95
Role of high mobility group (HMG) chromatin proteins in DNA repair
###end article-title 95
###begin article-title 96
HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their ends
###end article-title 96
###begin article-title 97
DNA bending versus DNA end joining activity of HMGB1 protein is modulated in vitro by acetylation
###end article-title 97
###begin article-title 98
###xml 80 93 80 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 80 93 <span type="species:ncbi:4932">S. cerevisiae</span>
Nhp6, an HMG1 protein, functions in SNR6 transcription by RNA polymerase III in S. cerevisiae
###end article-title 98
###begin article-title 99
High-mobility-group proteins NHP6A and NHP6B participate in activation of the RNA polymerase III SNR6 gene
###end article-title 99
###begin article-title 100
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Nhp6 is a transcriptional initiation fidelity factor for RNA polymerase III transcription in vitro and in vivo
###end article-title 100
###begin article-title 101
###xml 57 62 <span type="species:ncbi:4932">yeast</span>
Characterization of a high mobility group 1/2 homolog in yeast
###end article-title 101
###begin article-title 102
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
Hmo1, an HMG-box protein, belongs to the yeast ribosomal DNA transcription system
###end article-title 102
###begin article-title 103
###xml 118 142 118 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 118 142 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
An HMG protein, Hmo1, associates with promoters of many ribosomal protein genes and throughout the rRNA gene locus in Saccharomyces cerevisiae
###end article-title 103
###begin article-title 104
Hmo1 is required for TOR-dependent regulation of ribosomal protein gene transcription
###end article-title 104
###begin article-title 105
###xml 35 48 35 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 35 48 <span type="species:ncbi:4932">S. cerevisiae</span>
Actively transcribed rRNA genes in S. cerevisiae are organized in a specialized chromatin associated with the high-mobility group protein Hmo1 and are largely devoid of histone molecules
###end article-title 105
###begin article-title 106
Coordination of ribosomal protein and ribosomal RNA gene expression in response to TOR signaling
###end article-title 106
###begin article-title 107
###xml 4 28 4 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 4 28 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The Saccharomyces cerevisiae high mobility group box protein HMO1 contains two functional DNA binding domains
###end article-title 107
###begin article-title 108
###xml 54 78 54 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 54 78 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Interactions between N- and C-terminal domains of the Saccharomyces cerevisiae high-mobility group protein HMO1 are required for DNA bending
###end article-title 108
###begin article-title 109
###xml 29 52 29 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Deinococcus radiodurans</italic>
###xml 29 52 <span type="species:ncbi:1299">Deinococcus radiodurans</span>
Histone-like protein HU from Deinococcus radiodurans binds preferentially to four-way DNA junctions
###end article-title 109
###begin article-title 110
Localized DNA flexibility contributes to target site selection by DNA-bending proteins
###end article-title 110
###begin article-title 111
Dynamics of DNA duplexes containing internal G.T, G.A, A.C, and T.C pairs: hydrogen exchange at and adjacent to mismatch sites
###end article-title 111
###begin article-title 112
SRY, like HMG1, recognizes sharp angles in DNA
###end article-title 112
###begin article-title 113
HMG box proteins bind to four-way DNA junctions in their open conformation
###end article-title 113
###begin article-title 114
Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain
###end article-title 114
###begin article-title 115
###xml 94 119 94 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 94 119 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Mutagenesis of the HMGB (high-mobility group B) protein Cmb1 (cytosine-mismatch binding 1) of Schizosaccharomyces pombe: effects on recognition of DNA mismatches and damage
###end article-title 115
###begin article-title 116
###xml 31 36 <span type="species:ncbi:4932">yeast</span>
Mechanism of DNA compaction by yeast mitochondrial protein Abf2p
###end article-title 116
###begin article-title 117
Micromechanical analysis of the binding of DNA-bending proteins HMGB1, NHP6A, and HU reveals their ability to form highly stable DNA-protein complexes
###end article-title 117
###begin article-title 118
###xml 81 100 81 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thermotoga maritima</italic>
###xml 81 100 <span type="species:ncbi:2336">Thermotoga maritima</span>
DNA compaction by histone-like protein HU from the hyperthermophilic eubacterium Thermotoga maritima
###end article-title 118
###begin article-title 119
###xml 76 81 <span type="species:ncbi:4932">yeast</span>
Srs2 and Sgs1-Top3 suppress crossovers during double-strand break repair in yeast
###end article-title 119
###begin article-title 120
Conserved sequence preference in DNA binding among recombination proteins: an effect of ssDNA secondary structure
###end article-title 120

